Uveal Neoplasms clinical trials
The registry lists 4 studies for Uveal Neoplasms across 2 countries. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated 2026-06-01. Counting its narrower condition Uveal Melanoma too: 282 studies, 49 open.
Who runs them
Washington University School of Medicine (1) · Vastra Gotaland Region (1) · Udai Kammula (1) · Modulation Therapeutics, Inc. (1)
Coming up
Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.
All 2
- Mar 2027Targeted Alpha Particle Radiotherapy for Metastatic Uveal Melanoma · Modulation Therapeutics, Inc.
- Jul 2027Adoptive Transfer of Tumor Infiltrating Lymphocytes for Metastatic Uveal Melanoma · Udai Kammula
Who these studies take
No Uveal Neoplasms study is recruiting now.
Across all 4 studies, recruiting or not: 25% stop at 75 or younger and 0% at 65; 25% take children; 0% are for women only and 0% for men only; 0% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
Studies
Recruiting first, then most recently updated. Showing 4 of 4. search them.
- Adoptive Transfer of Tumor Infiltrating Lymphocytes for Metastatic Uveal MelanomaActive, not recruitingNCT03467516Phase 21 country
- Targeted Alpha Particle Radiotherapy for Metastatic Uveal MelanomaActive, not recruitingNCT05496686Phase 11 country
- The Scandinavian Randomized Controlled Trial of Isolated Hepatic Perfusion for Uveal Melanoma Liver MetastasesCompletedNCT01785316Phase 31 country
- Validation of a Molecular Prognostic Test for Eye MelanomaWithdrawnNCT004061201 country